Liposomal amphotericin B (L-AMB) is an anti-fungus medicine that has fewer side effects than traditional amphotericin B (AMB). Neurotoxicity of L-AMB has rarely been observed, and only one case of leukoencephalopathy during intravenous L-AMB has been reported. Herein, we described a patient with cryptococcal meningitis presenting with late-onset reversible encephalopathy associated with liposomal amphotericin B.
CITATION STYLE
Luo, S., Wen, H., Zhou, M., Wu, C., & Hong, D. (2022). Case report: Reversible encephalopathy associated with liposomal amphotericin B in a patient with cryptococcal meningitis. Frontiers in Neurology, 13. https://doi.org/10.3389/fneur.2022.1019137
Mendeley helps you to discover research relevant for your work.